Virginie Carmignac
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Virginie Carmignac has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Paul Kuentz
Université Marie et Louis Pasteur, CHU Besançon Franche‐Comté Oncobiologie Génétique Bioinformatique, FHU TRANSLAD Besançon France
6 shared publications - Pierre Vabres
Université Bourgogne Europe, INSERM, CTM UMR 1231, Equipe GAD Dijon France
5 shared publications - Martin Theiler
Pediatric Skin Center, Department of Dermatology, University Children’s Hospital Zurich, Zurich, Switzerland
4 shared publications Pierre Vabres
INSERM UMR1231, Bourgogne Franche-Comté University, Dijon, France
4 shared publicationsA. Sorlin
Centre de Génétique et Centre de référence « Anomalies du Développement et Syndromes Malformatifs » Hôpital d’Enfants Centre Hospitalier Universitaire de Dijon Dijon France
3 shared publicationsArthur Sorlin
INSERM UMR1231, Bourgogne Franche-Comté University, Dijon, France
3 shared publications
Latest Publications
- Open Access
- 22 December 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (6) , 1042-1051.e3
PTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma
- 22 December 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (6) , 1042-1051.e3
Open AccessPTPN11 Mosaicism Causes a Spectrum of Pigmentary and Vascular Neurocutaneous Disorders and Predisposes to Melanoma
- 1 November 2021
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (11) , 2225-1
Response to Resta et al.
- 1 November 2021
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (11) , 2225-1
Response to Resta et al.
- 7 September 2021
- Published by Wiley in British Journal of Dermatology
- Vol. 185 (6) , 1247-1249
Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome
Nevus comedonicus (NC) is a rare type of organoid epidermal nevus with comedones and inflammatory cysts 1 . It may be associated with extracutaneous manifestations (cataract, neurological and skeletal anomalies), defining NC syndrome 2 . Acne nevus, a clinically similar mosaic skin condition, is related to FGFR2, whereas postzygotic NEK9 mutations have been identified in four NC patients so far, including only one with NC syndrome 3 4 . Here we report on novel clinical findings, fibrous dysplasia and premature puberty in a case of NC syndrome associated with a NEK9 mutation.
- 7 September 2021
- Published by Wiley in British Journal of Dermatology
- Vol. 185 (6) , 1247-1249
Mosaic NEK9 mutation, fibrous dysplasia and premature puberty in naevus comedonicus syndrome
Nevus comedonicus (NC) is a rare type of organoid epidermal nevus with comedones and inflammatory cysts 1 . It may be associated with extracutaneous manifestations (cataract, neurological and skeletal anomalies), defining NC syndrome 2 . Acne nevus, a clinically similar mosaic skin condition, is related to FGFR2, whereas postzygotic NEK9 mutations have been identified in four NC patients so far, including only one with NC syndrome 3 4 . Here we report on novel clinical findings, fibrous dysplasia and premature puberty in a case of NC syndrome associated with a NEK9 mutation.
- 1 September 2021
- Published by Elsevier in Morphologie
- Vol. 105 (350) , S15
Naevus épidermique cérébriforme associé à FGFR2 : élargissement du spectre du naevus sébacé papillomateux et pédonculé
- 1 September 2021
- Published by Elsevier in Morphologie
- Vol. 105 (350) , S15
Naevus épidermique cérébriforme associé à FGFR2 : élargissement du spectre du naevus sébacé papillomateux et pédonculé
- 1 August 2021
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (8) , 1585
Correction to: Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities
- 1 August 2021
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (8) , 1585
Correction to: Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities
- 29 May 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (10) , E690-E693
Expanding the clinical spectrum of mosaic BRAF skin phenotypes
Click on the article title to read more.
- 29 May 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (10) , E690-E693
Expanding the clinical spectrum of mosaic BRAF skin phenotypes
Click on the article title to read more.
- 30 April 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (10) , 2085-2090
Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic FGFR2 mutations
Background: Postzygotic mutations in FGFR2 have been identified in mosaic forms of acne, keratinocytic epidermal nevi, nevoid acanthosis nigricans / rounded and velvety epidermal nevus and in two fetuses with papillomatous pedunculated sebaceous nevus (PPSN).Objectives: To determine the clinical and genetic characteristics of children with cerebriform, papillomatous and pedunculated variants of sebaceous nevi.Methods: Infants diagnosed with sebaceous nevi characterized by a cerebriform, papillomatous and/or pedunculated morphology over a 10‐year period (2010–2019) at three paediatric dermatology centres in Switzerland and France were included in this case series. Clinical and histological characteristics were assessed. Next‐generation sequencing was used to assess for FGFR2 mutations.Results: All nevi were located on the head, with a rounded or linear shape and a typical cerebriform, sometimes papillomatous and pedunculated, surface. No associated extracutaneous anomalies were found. Nevi harboured postzygotic mutations in the transmembrane domain of FGFR2 in 6/8 children (75%), either the known specific p.(Cys382Arg) mutation in 5 cases, or a novel mutation, p.(Val395Asp), in one.Conclusions: We found an exquisite genotype–phenotype correlation in these rare nevi, with specific postzygotic mutations in the transmembrane domain of FGFR2. As not all lesions were truly papillomatous and pedunculated, the term cerebriform sebaceous nevus (CSN) appears more suitable than PPSN to describe this entity. The cerebriform pattern of CSN is reminiscent of cutis gyrata, as seen in Beare–Stevenson syndrome, which is caused by closely related germline FGFR2 mutations. While clinically impressive, CSN seem to carry a good prognosis and a low risk for extracutaneous associations.
- 30 April 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (10) , 2085-2090
Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic FGFR2 mutations
Background: Postzygotic mutations in FGFR2 have been identified in mosaic forms of acne, keratinocytic epidermal nevi, nevoid acanthosis nigricans / rounded and velvety epidermal nevus and in two fetuses with papillomatous pedunculated sebaceous nevus (PPSN).Objectives: To determine the clinical and genetic characteristics of children with cerebriform, papillomatous and pedunculated variants of sebaceous nevi.Methods: Infants diagnosed with sebaceous nevi characterized by a cerebriform, papillomatous and/or pedunculated morphology over a 10‐year period (2010–2019) at three paediatric dermatology centres in Switzerland and France were included in this case series. Clinical and histological characteristics were assessed. Next‐generation sequencing was used to assess for FGFR2 mutations.Results: All nevi were located on the head, with a rounded or linear shape and a typical cerebriform, sometimes papillomatous and pedunculated, surface. No associated extracutaneous anomalies were found. Nevi harboured postzygotic mutations in the transmembrane domain of FGFR2 in 6/8 children (75%), either the known specific p.(Cys382Arg) mutation in 5 cases, or a novel mutation, p.(Val395Asp), in one.Conclusions: We found an exquisite genotype–phenotype correlation in these rare nevi, with specific postzygotic mutations in the transmembrane domain of FGFR2. As not all lesions were truly papillomatous and pedunculated, the term cerebriform sebaceous nevus (CSN) appears more suitable than PPSN to describe this entity. The cerebriform pattern of CSN is reminiscent of cutis gyrata, as seen in Beare–Stevenson syndrome, which is caused by closely related germline FGFR2 mutations. While clinically impressive, CSN seem to carry a good prognosis and a low risk for extracutaneous associations.
- Open Access
- 8 April 2021
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (8) , 1484-1491
Clinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities
- 8 April 2021
- Published by Elsevier in Genetics in Medicine
- Vol. 23 (8) , 1484-1491
Open AccessClinical spectrum of MTOR-related hypomelanosis of Ito with neurodevelopmental abnormalities
- Open Access
- 8 January 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Mutations in SKI in Shprintzen–Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization
Shprintzen–Goldberg syndrome (SGS) is a multisystemic connective tissue disorder, with considerable clinical overlap with Marfan and Loeys–Dietz syndromes. These syndromes have commonly been associated with enhanced TGF-β signaling. In SGS patients, heterozygous point mutations have been mapped to the transcriptional co-repressor SKI, which is a negative regulator of TGF-β signaling that is rapidly degraded upon ligand stimulation. The molecular consequences of these mutations, however, are not understood. Here we use a combination of structural biology, genome editing, and biochemistry to show that SGS mutations in SKI abolish its binding to phosphorylated SMAD2 and SMAD3. This results in stabilization of SKI and consequently attenuation of TGF-β responses, both in knockin cells expressing an SGS mutation and in fibroblasts from SGS patients. Thus, we reveal that SGS is associated with an attenuation of TGF-β-induced transcriptional responses, and not enhancement, which has important implications for other Marfan-related syndromes.
- 8 January 2021
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 10
Open AccessMutations in SKI in Shprintzen–Goldberg syndrome lead to attenuated TGF-β responses through SKI stabilization
Shprintzen–Goldberg syndrome (SGS) is a multisystemic connective tissue disorder, with considerable clinical overlap with Marfan and Loeys–Dietz syndromes. These syndromes have commonly been associated with enhanced TGF-β signaling. In SGS patients, heterozygous point mutations have been mapped to the transcriptional co-repressor SKI, which is a negative regulator of TGF-β signaling that is rapidly degraded upon ligand stimulation. The molecular consequences of these mutations, however, are not understood. Here we use a combination of structural biology, genome editing, and biochemistry to show that SGS mutations in SKI abolish its binding to phosphorylated SMAD2 and SMAD3. This results in stabilization of SKI and consequently attenuation of TGF-β responses, both in knockin cells expressing an SGS mutation and in fibroblasts from SGS patients. Thus, we reveal that SGS is associated with an attenuation of TGF-β-induced transcriptional responses, and not enhancement, which has important implications for other Marfan-related syndromes.
- 1 November 2020
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 63 (11) , 104036
Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation
- 1 November 2020
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 63 (11) , 104036
Compassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation